cp-675206,atezolizumab,durvalumab
astrazeneca,roche,pfizer
['mibc', 'imvigor 130', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'durva', 'danube ', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'imvigor,11', 'biomarker', 'bladder']
4. masterclass by and on 1l/combo/current soc in bladder cancer! discussion on soc prior to #gu23 
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own.